Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Idiopathic pulmonary fibrosis (IPF) is a highly heterogeneous condition and is likely to be initiated by many different forms of lung injury. Injury to the alveolar epithelium followed by aberrant repair is, however, recognised to be a central pathogenic mechanism in IPF.1 Histologically, there is evidence of epithelial cell hyperplasia and proliferation, particularly adjacent to fibroblastic foci, but also areas of epithelial apoptosis and denudation.2 In murine models of pulmonary fibrosis, inhibition of components of apoptotic signalling pathways abrogates both alveolar epithelial cell death and fibrosis. This has been achieved by treatment with caspase inhibitors or with antibody blockade of the Fas death receptor, these results being confirmed in mice deficient in murine Fas (lpr) or its ligand, gld.3 4 The mechanisms of epithelial cell apoptosis in human IPF are not clearly defined, although there is evidence that the Fas pathway may be upregulated resulting in caspase-dependent apoptosis.5 A recent paper has shown that apoptosis of epithelial cells derived from patients with IPF is specifically associated with markers of endoplasmic reticulum stress.6
In this issue of Thorax, Oikonomou and colleagues (see page 467) show that gelsolin—a regulator of cellular cytoskeleton dynamics—is upregulated in patients with IPF or fibrotic non-specific interstitial pneumonia, but not in other forms of interstitial lung disease, and that increased gelsolin expression correlates with reduced pulmonary function.7 The authors also studied mice deficient in gelsolin and showed that they are protected from bleomycin-induced inflammation and fibrosis, with reduced neutrophil emigration to the lungs, marked reduction in epithelial cell apoptosis and reduced collagen production. Further experiments in an acute lung injury model suggested an intrinsic deficit in emigration of gelsolin-deficient neutrophils into the lungs, in keeping with other studies and with the cytoskeletal functions of gelsolin.8 Nonetheless, adoptive transfer experiments, placing wild-type bone marrow into gelsolin-deficient mice and vice versa, showed that it was gelsolin expression in the resident tissue cells of the lung (as opposed to leucocytes) that was required for development of fibrosis.7
How does this fit with our knowledge of the biology of gelsolin? Gelsolin is a multifunctional protein which has a potent actin filament severing ability. This contributes to the rearrangements of the cellular cytoskeleton that underpin the motility of viable cells, with gelsolin deficiency reducing motility of inflammatory cells but increasing contractility of fibroblasts.8 In addition, however, gelsolin is a specific target of caspase-3, the central “executioner” protease of apoptosis.9 Cleavage of gelsolin during the later stages of apoptosis generates an N-terminal cleavage product (N-GSN) that causes cytoskeletal collapse resulting in apoptotic cell detachment and nuclear fragmentation, and it is the absence of this function that appears to be important in preservation of gelsolin-deficient alveolar epithelial cells following bleomycin injury.7 10 Gelsolin-deficient cells are shown to be protected from apoptosis in vitro, despite the presence of active caspase-3 and the efficient cleavage of other known caspase substrates.
In the light of these elegant studies, the authors speculate that actin-modifying drugs or specific targeting of the N-GSN gelsolin fragment might prove useful therapeutic strategies in IPF. Certainly their data support this idea, although inevitably there are some unanswered questions. The longer term phenotype of gelsolin-deficient epithelial cells that have received a pro-apoptotic insult but survived is unclear. The authors show that the cells have active caspase-3 and that other important cellular targets (eg, those involved in DNA repair) still undergo caspase-mediated cleavage and inactivation. Thus, gelsolin cleavage may be too far downstream in apoptotic signalling pathways for long-term cell rescue, and the longer term survival and proliferative potential of these cells—which are likely to have DNA damage—requires further study. Moreover, the ability of these “rescued” epithelial cells to initiate other pathological features of IPF is potentially important. The authors convincingly show reduced levels of KC, the principal neutrophil chemokine in mice and a functional homologue of human interleukin-8 (CXCL-8), and it would also be interesting and important to study other pathological events such as release of transforming growth factor β (TGF-β) and angiogenic factors from these cells following bleomycin treatment.
Gelsolin deficiency is not always associated either with reduced apoptosis or with amelioration of injury in other disease models. In a model of pulmonary ischaemia, defects in cytoskeletal remodelling in gelsolin-deficient mice were associated with increased permeability of the pulmonary endothelium.11 Gelsolin deficiency also results in worsening of ischaemic brain injury in mice.12 Fas-mediated liver fibrosis is exacerbated in gelsolin-deficient mice in association with selective apoptosis of sinusoidal endothelial cells, again suggesting that gelsolin has an important role in the maintenance of vascular barrier functions.13
Although not the main focus of these studies, the paper by Oikonomou and colleagues again demonstrates that neutrophilic inflammation is a component of bleomycin-induced lung injury in mice, as it is of human IPF where higher neutrophil counts are associated with more rapid disease progression.14 Reduced lung injury in gelsolin-deficient mice was associated with reduced neutrophil counts as well as with reduced alveolar epithelial cell apoptosis, compatible with a role for neutrophils in disease progression. However, the adoptive transfer experiments show that inhibition of epithelial injury reduces recruitment of wild-type neutrophils, suggesting that this inflammation is a consequence rather than a cause of epithelial injury.
Another interesting feature of this paper is the way in which gelsolin was identified as being worthy of study in IPF. The same group previously undertook expression profiling, comparing bleomycin-treated and untreated mice.15 Gelsolin was one of a group of genes shown to be upregulated in bleomycin-treated mice and to be biologically plausible as a known TGF-β target gene. The results presented in the current paper emphasise the potential utility of this approach for target identification in diseases of unknown aetiology.
Competing interests: None.